DEVELOPMENT OF POSIPHEN, AN INHIBITOR OF PHOSPHORYLATED TAU EXPRESSION, AS A TREATMENT OF TBI

$1,223,102FY2013Department of the ArmyDOD

Annovis Bio Inc

Investigators

DEVELOPMENT OF POSIPHEN, AN INHIBITOR OF PHOSPHORYLATED TAU EXPRESSION, AS A TREATMENT OF TBI · GrantIndex